As observed, we believe that our up-to-date manuscript incorporates scientific data not only about the pathophysiology behind DKD, involving the intricate relationship between hyperglycemia, inflammation and OS and the role of NRF2 in these processes, but also covers a larger spectrum of information on antioxidant therapy. This evidence concerns the gene NFE2L2 and diabetic kidney disease.